Europe
Evotec’s partner, second genome, begins a phase ii clinical trial for nash with licensed molecule, sgm-1019
Call for the world’s greatest minds to tackle the world’s biggest killers
Movers and Shakers is BioSpace’s weekly roundup of leadership appointments and changes within the biopharma world. Included this week are Genentech, Editas, Sage, Sangamo, and more.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Protein engineering extends immune cell vocabulary
A Dolomite Microfluidics’ set-up for high throughput single cell encapsulation is helping researchers at the Department of Medicine at Imperial College, London, to develop novel liposomal formulations for RNA vaccines targeting diseases such as HIV, influenza, rabies and chlamydia.
Auris Medical Holding AG today highlighted the advance publication of an article demonstrating that betahistine promotes the retrieval of forgotten memories in mice and in healthy human volunteers.
Pharming Group N.V. announced today that two abstracts were presented at The Western Society of Allergy, Asthma and Immunology (WSAAI) in Maui, Hawaii, USA on January 22-24, 2019.
Could Denmark become the site of Europe’s answer to Silicon Valley? The Danish government is banking on it. If it comes to fruition, the project could provide up to 12,000 life science jobs.
uBiome has announced a 10% reduction in staff, amounting to 55 jobs, while Theravance recently announced layoffs of 50 workers. Both companies have a significant presence in San Francisco.
PRESS RELEASES